[The uptake of daunorubicin, adriamycin and aclarubicin into leukemic cells measured by flow cytometry].
Arai
N
N
1st Dept. of Internal Medicine, Toho University, School of Medicine.
Umeda
M
M
Shirai
T
T
D015250:Aclarubicin / Q000493:pharmacokinetics*; D003630:Daunorubicin / Q000493:pharmacokinetics*; D004317:Doxorubicin / Q000493:pharmacokinetics*; D005434:Flow Cytometry; D006801:Humans; D007945:Leukemia, Lymphoid / Q000378:metabolism* / Q000473:pathology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism* / Q000473:pathology; D014407:Tumor Cells, Cultured / Q000378:metabolism
D015250:Aclarubicin; D004317:Doxorubicin; D003630:Daunorubicin